Alberto Ortiz, Silvia González Cuadrado, Corina Lorz, Jesús Egido.

Division of Nephrology. Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.

Received 12/01/95; Accepted 01/26/96; On-line 03/01/96

7. REFERENCES

1. C.B. Thompson. Apoptosis in the pathogenesis and treatment of disease. Science 267,1456-62 (1991).

2. J. Savill: Apoptosis and the kidney. J Am Soc Nephrol 5,12-21 (1994).

3. A. Ortiz-Arduan & E.G. Neilson. Apoptotic cell death in renal disease. Nefrología 14,391-407(1994).

4. J. Hughes, A. Mooney & J. Savill: Apoptosis: a key regulatory process in glomerulonephritis? J Nephrol 8,93-9 (1994).

5. H. Steller. Mechanisms and genes of cellular suicide. Science 267,1445-9 (1995).

6. P.A. Henkart. Apoptosis: O Death, where is thy sting? J Immunol 154,4905-8. 1995.

7. L.M. Schwartz, S.W. Smith, M.E. Jones & B.A. Osborne. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90,980-4 (1993).

8. E. Cuende, J.E. Ales-Martinez, L.Ding, M. Gonzalez-Garcia, A. Martinez & G. Nuñez. Programmed cell death by bcl-2-dependent and -independent mechanisms in B lymphoma cells. EMBO J 12,1555-60 (1993).

9. A.R. Clarke, C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper & A.H. Wyllie. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-52 (1993).

10. J.F. Kerr, A.H. Wyllie & A.R. Currie. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-57 (1972).

11. M.J. Arends & A.H. Wyllie. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32,223-254 (1991).

12. J.J. Cohen, R.C. Duke, V.A. Fadok & K.S. Sellins. Apoptosis and programmed cell death in immunity. Ann Rev Immunol 10,267-293 (1992).

13. B.A. Barres, I.K. Hart, H.S.R. Coles, J.F. Burne, J.T. Voyvodic JT, Richardson WD & Raff MC. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 7031-46 (1992).

14. H.S.R. Coles, J.F. Burne & M.C. Raff. Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118,777-784 (1993).

15. G.C. Gobe & R.A. Axelsen. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Lab Invest 56,273-281 (1987).

16. K. Schulze-Osthoff, H. Walczak, W. Droge & P.H. Krammmer. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127,15-22 (1994).

17. G.C. Gobe, R.A. Axelson & J.W. Searle. Cellular events in experimental unilateral ischaemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 63:770-779 (1990).

18. V. Triaca, J. Levine & W. Lieberthal. Mechanisms of death induced by cisplatin in renal tubular epithelial cells. J Am Soc Nephrol 6,1006 (1995) abstract

19. M.C. Raff. Social controls on cell survival and cell death. Nature 356,397-400 (1992).

20. A. Ortiz, S.L. Karp & E.G. Neilson. Clusterin (SGP2) mRNA expression by mesangial cells and its regulation by cytokines. J Am Soc Nephrol 4,626 (1993), abstract

21. A. Ortiz, S.L. Karp, T.M. Danoff & E.G. Neilson. Expression of survival promoting bcl2 oncogene by renal cells and whole kidney. J Am Soc Nephrol 4,742 (1993) abstract

22. A.J. Baker, A. Mooney, J. Hughes, D. Lombardi, R.J. Johnson & J. Savill. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94, 2105-2116 (1994).

23. H. Morita, T. Shinzato, A. Oyabu, H. Habuchi, H. Yamada, K. Maeda & K. Kimata. Basic fibroblast growth factor (bFGF) requires heparan sulfate that contains bFGF-binding domains for regulating glomerular cell apoptosis. J Am Soc Nephrol 6, 772 (1995) abstract

24. A. Mooney & J. Savill. Insulin-like growth factor-1 (IGF-1) is a candidate mesangial cell (MC) survival factor, inhibiting MC apoptosis in vitro. J Am Soc Nephrol 6, 877 (1994) abstract

25. N. Boudreau, C.J. Sympson, Z. Werb & M.J. Bisell. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267,891-893 (1995)

26. H. Sugiyama, N. Kashihara, T. Sekikawa, Y. Maeshima, K. Okamoto, K. Kanao, H. Makino & Z. Ota. Cell-matrix interactions modulate mesangial cell apoptosis. J Am Soc Nephrol 6,912 (1995) abstract.

27. M. Gómez-Chiarri, A. Ortiz, J.L. Lerma, F. Mampaso, E. González & J Egido. Involvement of tumor necrosis factor and platelet activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70,449-459 (1994)

28. Z.H. Liu, G.E. Striker, M. Stetler-Stevenson, P. Fukushima, P.D. Stahl & L.J. Striker. Tumor necrosis factor-alpha and IL-1alpha induce apoptosis in glomerular mesangial cells, but not in endothelial cells. J Am Soc Nephrol 6, 771 (1995), abstract.

29. S. Gonzalez-Cuadrado, A. Ortiz, S. Karp, S. Li, B. Cizman, M.J. Lopez-Armada, M. Madaio, J. Egido & E.G. Neilson. The Fas ligand (FasL)-Fas (CD95) system in the kidney. J Am Soc Nephrol 5,748 (1994), abstract

30. H. Sugiyama, N. Kashihara, Y. Yamasaki, T. Sekikawa, K. Okamoto, K. Kanao, Y. Maeshima, H. Makino & Z. Ota. Reactive oxygen species induce apoptosis in cultured mesangial cells. J Am Soc Nephrol 5,796 (1994), abstract

31. T. Sato, M.G.A. van Dixhoom, W.E.M. Schroeijers, T.W.J. Huizinga, C.P.M. Reutelingsperger, L.A. van Es & M.R. Daha. Anti-Thy-1 monoclonal antibodies induce apoptosis of cultured rat mesangial cells. J Am Soc Nephrol 6,883 (1995), abstract

32. J. Svennison, E. Öslund & A. Aperia. The role of ceramide PKC and PP2A in the induction of apoptosis in the developing kidney. J Am Soc Nephrol 6,710 (1995), abstract.

33. L.M. Obeid, C.M. Linardic, L.A. Karolak & Y.A. Hannun. Programmed cell death induced by ceramide. Science 259,1769-1771 (1993)

34. N. Ueda, P.D. Walker, S.M. Hsu & S.V. Shah. Activation of a 15-kDa endonuclease in hypoxia/reoxygenation injury without morphologic features of apoptosis. Proc Natl Acad Sci USA 92,7202-6 (1995)

35. J.C. Louis, E. Magal, S. Takayama & S. Varon. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259,689-692 (1993)

36. A.M. Zubiaga, E. Munoz & B.T. Huber. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid induced apoptosis. J Immunol 149,107-112 (1992)

37. A. Ortiz & E.G. Neilson. Expression of bax and bcl-x, members of the bcl-2 gene family, in murine tubular cells and acute renal failure. J Am Soc Nephrol 5,905 (1994), abstract

38. M.O. Hengartner & H.R. Horvitz. Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev 4,581-6 (1994)

39. K. White, M.E. Grether, J.M. Abrams, L. Young, K. Farrell & H. Steller. Genetic control of programmed cell death in Drosophila. Science 264,677-683 (1994)

40. J.L. Cleveland & J.N. Ihle. Contenders in FasL/TNF death signaling. Cell 81,479-482 (1995)

41. S.J. Martin & D.R. Green. Protease activation during apoptosis: death by a thousand cuts? Cell 82,349-352 (1995)

42. M.D. Hengartner & H.R. Horvitz. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76,665-76 (1994)

43. D.T. Chao, G.P. Linette, L.H. Boise, L.S. White, C.B. Thompson & S.J. Korsmeyer. Bcl-x_L and Bcl-2 repress a common pathway of cell death. J Exp Med 182,821-828 (1995)

44. I. Fath, F. Schweighoffer, I. Rey & M.C. Multon, J. Boiziau, M. Duchesne & B. Tocque. Cloning of a Grb2 isoform with apoptotic properties. Science 264,971-4 (1994)

45. C.A. Smith, T. Farrah & R.G. Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and cell death. Cell 76,959-962 (1994)

46. N. Itoh & S. Nagata. A novel domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268:10932-10937 (1993)

47. L.A. Tartaglia, T.M. Ayres, G.H.W. Wong & D.V. Goeddel. A novel domain within the 55kd TNF receptor signals cell death. Cell 74,845-853 (1993)

48. J. Bigda, I. Beletsky, C. Brakebusch, Y. Varfolomeev, H. Engelmann, J. Bigda, H. Holtmann & D. Wallach. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 180,445-60 (1994)

49. S. Nagata & P. Golstein. The Fas death factor. Science 267,1449-1456 (1995)

50. B.C. Trauth, C. Klas, A.M.J. Peters, S. Matzku, P. Moller, W. Falk, K.M. Debatin & Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305 (1989)

51. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down regulated with the receptor of TNF. J Exp Med 1989;169:1747-1756

52. J. Ogasawara, R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugal, Y. Kitamura, N. Itoh, T. Suda & S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364,806-809 (1993)

53. T. Suda, T. Takahashi, P. Golstein & S. Nagata. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178 (1993)

54. E. Rouvier, M.F. Luciani & P. Golstein. Fas involvement in Ca²⁺-independent T cell-mediated cytotoxicity. J Exp Med 177,195-200 (1993)

55. D. Kägi, F. Vignaoux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner & P. Golstein. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265,528-530 (1994)

56. S.T. Ju, D.J. Panka, H. Ciu, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger & A.M. Marshak-Rothstein. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373,444-448 (1995)

57. J. Dhein, H. Walczak, C. Bäumler, K.M. Debatin & P.H. Krammer. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373,438-441 (1995)

58. M.R. Alderson, R.J. Armitage, E. Maraskovsky, T.W. Tough, E. Roux, K. Schooley, F. Ramsdell & D.H. Lynch. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178, 2231-2235 (1993)

59. T. Takahashi, M. Tanak, C.T. Brannan, N.A. Jenkins, N.G. Copeland, T.S. Suda & S. Nagata. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76,969-976 (1994)

60. R. Watanabe-Fukunaga, C. Brannan, N.G. Copeland, N.A. Jenkins & S. Nagata. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356,314-317 (1992)

61. J.L. Chu, J. Drappa, A. Parnassa, E. & K.B. Elkon. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 178,723-730 (1993)

62. G.H. Fisher, F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Yin, W. Strober, M.J. Lenardo & J.M. Puck. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946 (1995)

63. F. Rieux-Laucat, F. Le Deist, C. Hivroz, I.A.G. Roberts, K.M. Debatin, A. Fischer & J.P. de Villartay. Mutations in Fas associated with human lymphproliferative syndrome and autoimmunity. Science 268,1347-1349 (1995)

64. J. Cheng, T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Kiefer, P.J. Barr & J.D. Mountz. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762 (1994)

65. A. Ortiz & E.G. Neilson. Apoptosis-related Fas RNA is expressed by renal cells and increased in renal damage. J Am Soc Nephrol 4:496 (1993) abstract

65.b. S. Gonzalez-Cuadrado, M.J. López-Armada, C. Gómez-Guerrero, D. Subirá, A. Garcia-Sahuquillo, A. Ortiz-Gonzalez, E.G. Neilson, J. Egido & A. Ortiz. Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 49 (1996)(in press)

66. J. Drappa, N. Brot & K.B. Elkon. The Fas protein is expressed at high levels on CD4⁺CD8⁺ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain MRL lpr/lpr. Proc Natl Acad Sci USA 90,10340-10344, (1993)

67. T. Sato, S. Irie, S. Kitada & J.C. Reed. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268,411-414 (1995)

68. S.M. Mariani, B. Matiba, E.A. Armandola & P.H. Krammer. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 24,3119-23 (1994)

69. M. Kimura, Y. Ogata, K. Shimada, T. Wakabayashi, H. Onoda, T. Katagiri & A. Matsuzawa. Nephritogenicity of the lpr^cg gene on the MRL background. Immunology 76,498-504 (1993)

70. M.P. Boldin, I.L. Mett, E.E. Varfolomeev, Z. Pancer, I. Chumakov, Y. Shemer-Avni, J.H. Camonis JH, Wallach D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem 270,387-391 (1995)

71. B.Z. Stanger, P. Leder, T.H. Lee, E. Kim & B. Seed. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes death. Cell 81,513-523 (1995)

72. H. Hsu, J. Xiong & D.V. Goeddel. The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell 81, 495-504 (1995)

73. M.P. Boldin, E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis & D. Wallach. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270,7795-7798 (1995)

74. A.M. Chinnaiyan, K. O'Rourke, M. Tewari & V.M. Dixit. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81,505-512 (1995)

75. G.I. Evan, A.H. Wyllie, C. Gilbert, T. Littlewood, H. Land H, Brooks M, Waters C, Penn L & Hancock D. Induction of apoptosis in fibroblasts by c-myc. Cell 69,119-128 (1992)

76. D.S. Askew, R.A. Ashmun, B.C. Simmons & J.L. Cleveland. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6,1915-1922 (1991)

77. R. Bissonnette, F. Echeverri, A. Mahboudi & D. Green. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359,552-554 (1992)

78. D. Reisman, N.B. Elkind, B. Roy, J. Beamon & V. Rotter: c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ 4,57-65 (1993)

79. A.J. Wagner, J.M. Kokontis & N. Hay. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 8,2817-30 (1994)

80. H. Hermeking & D. Eick. Mediation of c-Myc-induced apoptosis by p53. Science 265,2091-3 (1994)

81. C.C. Harris & M. Hollstein. Clinical implications of the p53 tumor-suppressor gene. New Engl J Med 329,1318-1327 (1993)

82. M. Chopp, Y. Li, Z.G. Zhang & S.O. Freytag: p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys Res Commun 182,1201-1207 (1992)

83. S.W. Lowe, E.A. Schmitt, S.W. Smith, B.A. Osborne, T. Jacks. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362,847-849 (1993)

84. R.C. Bates, A. Buret, D.F. van Helden, M.A. Horton & G.F. Burns. Apoptosis induced by inhibition of intercellular contact. J Cell Biol 125,403-415 (1994)

85. Y.M. Zhu, D.A. Bradbury & N.H. Russell. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer 69,468-72 (1994)

86. R.E. Yonish, D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi & M. Oren. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 353:345-34 Falta el año

87. T. Miyashita, S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman & J.C. Reed. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9,1799-805 (1994)

88. T. Miyashita & J.C. Reed. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80,293-299 (1995)

89. C. Caelles, A. Helmberg & M. Karin. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370,220-223 (1994)

90. S.K. Chiou, L. Rao & E. White. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14,2556-63 (1994)

91. F. Collatta, N. Polentarutti, N. Siboni & A. Mantovani. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267,18278-18283 (1992)

92. S. Estus, W.J. Zaks, R.S. Freeman, M. Gruda, R. Bravo, E.M. Johnson. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127,1717-1727 (1994)

93. J.D. Woronicz, B. Calnan, V. Ngo & A. Winoto. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367,277-81 (1994)

94. Z.G. Liu, S.W. Smith, K.A. McLaughlin, L.M. Schwartz & B.A. Osborne. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367,281-4 (1994)

95. K. Yazdanbakhsh, J.W. Choi, Y. Li, L.F. LauF & Y. Choi. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc Natl Acad Sci USA 92,437-41 (1995)

96. M. Miura, H. Zhu, R. Rotello, E.A. Hartwieg & J. Yuan. Induction of apoptosis in fibroblasts by IL-1ß-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75,653-660 (1993)

97. J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis & H.R. Horvitz. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1ß-converting enzyme. Cell 75,641-652 (1993)

98. K. Kuida, J.A. Lippke, G. Ku, M.W. Harding, D.J. Livingston, M.S.S. Su & R.A. Flavell. Altered cytokine export and apoptosis in mice deficient in interleukin-1ß converting enzyme. Science 267,2000-3 (1995)

99. Y. Gu, C. Sarnecki, R.A. Aldape, D.J. Livingston & M.S. Su. Cleavage of poly(ADP-ribose) polymerase by interleukin-1 ß converting enzyme and its homologs TX and Nedd-2. J Biol Chem 270,18715-8 (1995)

100. M. Tewari, L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen & V.M. Dixit. YAMA/CPP32ß, a mammalian homologue of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809 (1995)

101. D.W. Nicholson, A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, N.A. Munday, S.M. Raju, M.E. Samulson, T.T. Yamin, V.L. Yu & D.K. Miller. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376,37-43 (1995)

102. L. Wang, M. Miura, L. Bergeron, H. Zhu & J. Yuan. Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78,739-750 (1994)

103. C. Faucheu, A. Diu, A.W.E. Chan, A.M. Blanchet, C. Miossec, F. Herve, V. Collard-Dutilleul, Y. Gu, R.A. Aldape, J.A. Lippke, C. Rocher, M.S.S, Su, D.J. Livingston, T. Hercend & J.L. Lalanne. A novel human protease similar to the interleukin-1 ß converting enzyme induces apoptosis in transfected cells. EMBO J 14,1914-1922 (1995)

104. J. Kamens, M. Paskind, M. Hugunin, R.V. Talanian, H. Allen, D. Banach, N. Bump, M. Hackett, C.G. Johnston, P. Li, J.A. Mankovich, M. Terranova & T. Ghayur. Identification and characterization of ICH-2, a novel member of the interleukin-1 ß-converting enzyme family of cysteine proteases. J Biol Chem 270,15250-6 (1995)

105. N.A. Munday, J.P. Vaillancourt, A. Ali, F.J. Casano, D.K. Miller, S.M. Molineaux, T.T. Yamin, V.L. Yu & D.W. Nicholson. Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 270,15870-15876 (1995)

106. N.A. Thornberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, M.J. Kostura, D.K. Miller, S.M. Molineaux, J.R. Weidner, J. Aunins, K.D. Ellison, J.M. Ayala, F.J. Casano, J. Chin, G.J.F. Ding, L.A. Egger, E.P. Gaffney, G. Limjuco, O.C. Palyha, S.M. Raju, A. M. Ralando, J.P. Salley, T.T. Yamin, T.D. Lee, J.E. Shivley, M. MacCross, R.A. Mumford, J.A. Schmidt & M.J. Tocci. A novel heterodimeric cystein protease is required for interleukin-1ß processing in monocytes. Nature 356,768-774 (1992)

107. M.K. Squier, A.C. Miller, A.M. Malkinson & J.J. Cohen. Calpain activation in apoptosis. J Cell Physiol 159,229-237 (1994)

108. J. Turck, H. Radeka & D.H. Lovett. The N-terminal propiece of interleukin 1a is a pro-apoptotic factor. J Am Soc Nephrol 6,779 (1995) abstract

109. D. Hockenbery, G. Nuñez, C. Milliman, R.D. Schreiber & S.J. Korsmeyer. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348,334-336 (1990)

110. M.D. Jacobson, J.F. Burne, M.P. King, T. Miyashita, J.C. Reed & M.C. Raff. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361,365-369 (1993)

111. D.M. Hockenbery, Z.N. Oltvai, X.M. Yin, C.L. Milliman & S.J. Korsmeyer. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75,241-251 (1993)

112. D.J. Kane, T.A. Sarafian, R. Anton, H. Hahn, E.B. Gralla, J.S. Valentine, T. Ord & D.E. Bredesen. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262,1274-1277 (1993)

113. S. Shimizu, Y. Eguchi, H. Kosaka, W. Kamike, H. Matsuda & Y. Tsujimoto. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374,811-813 (1995)

114. M.D. Jacobson & M.C. Raff. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374,814-816 (1995)

115. S. Takayama, T. Sato, S. Krajewski, K. Kochel, S. Irie, J.A. Millan & J.C. Reed. Cloning and functional analysis of BAG-1: a novel Bcl2 binding protein with anti-cell death activity. Cell 80,279-284 (1995)

116. J.C. Reed. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124,1-6 (1994)

117. A. Sapirstein, R. Spech, R. Witzgall & J.V. Bonventre. BCL-2 prevents cytosolic PLA2-mediated cell injury in renal epithelial cells. J Am Soc Nephrol 6,988 (1995) abstract

118. A. Mooney & J. Savill. Lack of correlation between mesangial cell susceptibility to apoptosis and intracellular levels of BCL-2 and Bax proteins. J Am Soc Nephrol 6,877 (1995) abstract

119. D.P. Lebrun, R.A. Warncke & M.L. Cleary. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142,743-753 (1993)

120. D.M. Hockenbery, M. Zutter, W. Hickey, M. Nahm & S.J. Korsmeyer. BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88,6961-6965 (1991)

121. A. Strasser, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory & A.W. Harris: Enforced bcl2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88,8661-8665 (1991)

122. D.J. Veis, C.M. Sorenson, J.R. Shutter & S.J. Korsmeyer. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75,229-240 (1993)

123. L.H. Boise, M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez & C.B. Thompson. bcl-x, a bcl-2-related gene that functions as a dominant regulator of cell death. Cell 74,597-608 (1993)

124. W. Fang, J.J. Rivard, D.L. Mueller & T.W. Behrens. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J Immunol 153,4388-98, 1994.

125. A.R. Gottschall, L.H. Boise, C.B. Thompson & J. Quintans. Identification of immunosuppresant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91,7350-7354 (1994)

126. M. Gonzalez-Garcia, R. Perez Ballesteros, L. Ding, L. Duan, L.H. Boise, C.B. Thompson & G. Nuñez. Bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120,3033-3042 (1994)

127. Z.N. Oltvai, C.L. Milliman & S.J. Korsmeyer. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74,609-619 (1993)

128. E. Yang, J. Zha, J. Jockel, L.H. Boise, C.B. Thompson & S.J. Korsmeyer. Bad, a heterodimeric partner for BclxL and Bcl2, displaces Bax and promotes cell death. Cell 80,285-291 (1995)

129. X.M. Yin, Z.N. Oltval & S.J. Korsmeyer. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369,321-3 (1994)

130. S. Krajewski, M. Krajewska, A. Shabaik, T. Miyashita, H.G. Wang & J.C. Reed. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145,1323-36 (1994)

131. S.N. Farrow, J.H.M. White, I. Martinou, T. Raven, K.T. Pun, C.J. Grinham, J.C. Martinou & R. Brown. Cloning of a Bcl2-homologue by interaction with adenovirus E1B 19K. Nature 374,731-733 (1995)

132. T. Chittenden, E.A. Harrington, R. O'Connor, C. Flemington, R.J. Lutz, G.I. Evan & B.C. Guild. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374,733-736 (1995)

133. M.C. Kiefer, M.J. Brauer, V.C. Powers, J.J. Wu, S.R. Umansky, L.D. Tomei & P.J. Barr. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374,733-739 (1995)

134. M.E. Rosenberg, J. Dvergsten, R. Correa-Rotter. Clusterin: an enigmatic protein recruited by diverse stimuli. J Lab Clin Med 121,205-214 (1993)

135. C. Pilarsky, W. Haase & C. Koch-Brandt. Stable expression of gp80 (clusterin), a secretory protein implicated in programmed cell death, in transfected BHK-21 cells. Biochim Biophys Acta 1179,306-310 (1993)

136. L.E. French, A. Chonn, D. Ducrest, B. Baumann, D. Belin, A. Wohlwend, J.Z. Kiss, A.P. Sappino, J. Tschopp & J.A. Schifferli. Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J Cell Biol 122,1119-1130 (1993)

137. JA. Sensibar, D.M. Sutkowski, A. Raffo, R. Buttyan, M.D. Griswold, S.R. Sylvester, J.M. Kozlowski & Lee C. Prevention of cell death induced by tumor necrosis factor in LNCaP cells by overexpression of sulfated glycoprotein-2 (Clusterin). Cancer Res 55,2431-2437 (1995)

138. A. Ortiz, J. Alonso, M. Gomez-Chiarri, J.L. Lerma, D. Serón, E. Condom, E. González & J. Egido. Fibronectin decreases glomerular lesions and synthesis of TNF, PAF and fibronectin in proliferative glomerulonephritis. Clin Exp Immunol 101,334-340 (1995)

139. M. Gomez-Chiarri, A. Ortiz, S. González-Cuadrado, D. Serón, S.N. Emancipator, T.A. Hamilton, A. Barat, J.J. Plaza, E. González & J. Egido. Interferon-inducible protein 10 (IP-10) is highly expressed in rats with experimental nephrosis. Am J Pathol 148, 310-311 (1996)

140. J. Savill. Apoptosis: a mechanism for regulation of the cell complement of inflamed glomeruli. Kidney Int 41,607-612 (1992)

141. J.E. Albina, S. Cui, R.B. Mateo & J.S. Reichner. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150,5080-5085 (1993)

142. T.M. Danoff, M.Y. Chiang, A. Ortiz & E.G. Neilson. Transcriptional regulation of murine RANTES in proximal tubular cells. J Am Soc Nephrol 4:599, (1993) abstract

143. J.S. Savill, P.M. Henson & C. Haslett. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge sensitive" recognition mechanism. J Clin Invest 84,1518-1527 (1989)

144. J. Savill, I. Dransfield, N. Hogg & C. Haslett. Vitronectin receptor mediated phagocytosis of cells undergoing apoptosis. Nature 343,170-173 (1990)

145. J. Savill, N. Hogg, Y. Ren & C. Haslett. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90,1513-1522 (1992)

146. B. Price, W. Lieberthal, V. Triaca, J. Fitzpatrick, J. Koh & J. Levine. The lupus anticoagulant recognizes an epitope on the membranes of apoptotic cells. J Am Soc Nephrol 5,763 (1994) abstract

147. K.A. Hogquist, M.A. Nett, E.R. Unanue & D.D. Chaplin. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 88,8485-9 (1991)

148. J.A. Trial, H.H. Birdsall, J.A. Hallum, M.L. Crane & R.D. Rossen. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effect of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocyte phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype. J Clin Invest 95,1690-1701 (1995)

149. A.N. Akbar, J. Savill, W. Gombert, M. Bofill, N.J. Borthwick, F. Whitelaw, J. Grundy, G. Janossy & M. Salmon. The specific recognition by macrophages of CD8+, CD45RO⁺ T cells undergoing apoptosis: a mechanism for T cell clearance during resolution of viral infections. J Exp Med 180,1943-1947 (1994)

150. M.K.B. Whyte, L.C. Meagher, J. NacDermott & C. Haslett. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150,5124-5134 (1993)

151. D.F. Mangan & S.M. Wahl. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 147,3408-3412 (1991)

152. D.F. Mangan, G.R. Welch & S.M. Wahl. Lipopolysaccharide, tumor necrosis factor alpha and IL-1 ß prevent programmed cell death (apoptosis) in human peripheral blood lymphocytes. J Immunol 146,1541-1546 (1991)

153. J. Savill, J. Smith, C. Sarraf, Y. Ren, F. Abbott & A. Rees. Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42,924-936 (1992)

154. T.D. Hewitson, K.G.C. Smith & G.J. Becker. Apoptosis in resolution of renal infective tubulointerstitial nephritis. J Am Soc Nephrol 6,896 (1995) abstract

155. L.A. Casciola-Rosen, G. Anhalt & A. Rosen. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179,1317-1330 (1994)

156. W.J.M. Tax, C. Kramers, M.C.J. van Bruggen & J.H.M. Berden. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 48,666-673 (1995)

157. M.J. Szabolcs, L. Ward, R. Buttyan & V. D'Agati. Apoptosis in human renal biopsies. J Am Soc Nephrol 5,844 (1994) abstract

158. D.J. Harrison. Cell death in the diseased glomerulus. Histopathology 12,679-683 (1988)

159. A. Oyabu, H. Morita, T. Shinzato, K. Kimata, H. Yamada & K. Maeda. Apoptosis: a candidate for the major mechanism mediating immediate mesangial cells death in thy-1 nephritis. J Am Soc Nephrol 6,880 (1995) abstract

160. A. Shimizu, M. Ishizaki, H. Kitamura, Y. Masuda, K. Muroga, Y. Sugisaki & N. Yamanaka. Complement mediates mesangial cell apoptosis in the glomerulonephritis. J Am Soc Nephrol 6, 884 (1995) abstract

161. T. Oikawa, J. Kakuchi & A. Fogo. Interleukin 1ß conferring enzyme (ICE) is increased in association with pathological apoptosis in the sclerotic kidney. J Am Soc Nephrol 6,1026 (1995) abstract

162. A. Shimizu, N. Nakao, K. Muroga, H. Kitamura, Y. Masuda, M. Ishizaki, Y. Sugisaki, N. Yamanaka & Y. Natori. Apoptosis in progression process of experimental crescentic glomerulonephritis. J Am Soc Nephrol 5,769 (1994) abstract

163. H. Sugiyama, N. Kashihara, Y. Yamasaki, T. Sekikawa, K. Okamoto, K. Kanao, Y. Maeshima, H. Makino & Z. Ota. Apoptosis of glomerular cells in human glomerular disease. J Am Soc Nephrol 5, 844 (1994) abstract

164. A. Ortiz, C. Bustos, J. Alonso, R. Alcazar, M.J. López-Armada, J.J. Plaza, E. Gonzalez & J. Egido. Involvement of tumor necrosis factor alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol 24,53-78 (1995)

165. A. Yoshimura, K. Inui, Y. Sugenoya, S. Iwasaki & T. Ideura. Apoptosis-preventing Bc1-2 protein and its counter-active Bax mRNA expression in glomeruli with human proliferative glomerulonephritis. J Am Soc Nephrol 6,932 (1995) abstract

166. K. Yoshioka, T. Takemura & K. Murakami. Expression of FAS (APO-1) antigen and BCL-2 1N human glomerulonephritis. J Am Soc Nephrol 1995; 6,932 (1995) abstract

167. M. Schumer, M.C. Colombel, I.S. Sawczuk, G. Gobe, J. Connor, K.M. Otoole, C.A. Olsson, G.J. Wise & R. Buttyan. Morphologic, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140,831-838 (1992)

168. A. Shimizu & N. Yamanaka. Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 64,171-180 (1993)

169. L. Truong, G. Petrusevska, G. Yang, T. Gurpinar, S. Shappell, J. Lechago, D. Rouse & W. Suki. The kinetics of cell apoptosis and proliferation in chronic obstructive uropathy. J Am Soc Nephrol 6, 888 (1995) abstract

170. G.M. Ledda-Columbano, A. Columbano, P. Coni, G. Faa & P. Pani. Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol 135,657-662 (1989)

171. E.J. Nouwen, W.A. Verstrepen, N. Buyssens, M.Q. Zhu & M.E. DeBroe. Hyperplasia, hypertrophy and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 70,479-493 (1994)

172. R. Safirstein, A.Z. Zelent & P.M. Price. Reduced renal pre-pro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int 36,810-815 (1989)

173. W.A. Verstrepen, E.J. Nouwen, X.S. Yue & M.E. De Broe. Altered growth factor expression during proximal tubular necrosis and regeneration. Kidney Int 43,1267-1279 (1993)

174. G.R. Walton, R. Buttyan, E. Garcia Montes, C.A. Olsson, T.G. Hensle & I.S. Sawczuk. Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148,510-514 (1992)

175. L.M. Shulman, Y. Yuhas, I. Frolkis, S. Gavendo, A. Knecht & H.E. Eliahou. Glycerol induced ARF in rats is mediated by tumor necrosis factor alpha. Kidney Int 43,1397-1401 (1993)

176. T. Taira, A. Yoshimura, K. Inui, K. Iizuka, S. Iwasaki & T. Ideura. Apoptosis-inducible Fas antigen and p53 protein are expressed in the kidney in the repair process from experimental and human acute tubular necrosis. J Am Soc Nephrol 6,990 (1995) abstract

177. B.D. Cowley, L.J. Chadwick, J.J. Grantham & J.P. Calvet. Sequential protooncogene expression in regenerating kidney following acute renal injury. J Biol Chem 264,8389-8393 (1989)

178. A.J. Ouellette, R.A. Malt, V.P. Sukhatme & J.V. Bonventre. Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischaemia and during compensatory hypertrophy in mice. J Clin Invest 85,766-771 (1990)

179. S. Ishidoya, J. Morrissey, R. McCracken & S. Klahr. Regulation of p53, p21 and GADD45 mRNA during unilateral ureteral obstruction. J Am Soc Nephrol 6,769 (1995) abstract

180. R.L. Chevalier, C.D. Smith, S. Krajewski & J.C. Reed. Renal apoptosis following unilateral ureteral obstruction is associated with suppression of bcl-2. J Am Soc Nephrol 6,976 (1995) abstract

181. K.A. Nath. Tubulointerstitial changes as major determinants in the progression of renal damage. Am J Kidney Dis 20,1-17 (1992)

182. I. Bódi, A.A. Abraham & P.L. Kimmel. Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 26,286-291 (1995)

183. G.C. Gobe & R.A. Axelsen. The role of apoptosis in the development of renal cortical tubular atrophy associated with healed experimental renal papillary necrosis. Pathology 23,213-223 (1991)

184. F. Strutz, H. Okada, C.W. Lo, T.D. Danoff, R.L. Carone, J.E. Tomaszewski & E.G. Neilson. Identification and characterization of a new fibroblast specific marker: FSP-1. J Cell Biol 130,393-406 (1995)

185. H.P. Rodemann & G.A. Muller. Abnormal growth, clonal proliferation and 35S-methionine polypeptide pattern of fibroblasts derived from kidneys with interstitial fibrosis. Proc Soc Exp Biol Med 195,57-63 (1990)

186. I. Darby, O. Skalli & G. Gabbiani. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63,21-29 (1990)

187. D. Woo. Apoptosis and loss of renal tissue in kidney polycystic diseases. N Engl J Med 333,18-25 (1995)

188. M. Trudel, V. D'Agati & F. Constantini. c-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 39,665-671 (1991)

189. M.A. Harding, V.H. Gattone, J.J. Grantham & J.P. Calvet. Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Kidney Int 41,317-325 (1992)

190. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81,289-298 (1995)

191. C. Koseki, D. Herzlinger & Q. Al-Awqati. Apoptosis in metanephric development. J Cell Biol 119,1327-1333 (1992)

192. H. Sariola, M. Saarma, K. Sainio, U. Arumae, J. Palgi, A. Vaahtokari, I. Thelseff & A. Karavanov. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 254,571-573 (1991)

193. S.A. Rogers, C.M. Sorenson & M.R. Hammerman. Polypeptide growth factors act as survival factors for developing kidneys from BCL-2-/-mice. J Am Soc Nephrol 6, 708 (1995) abstract

194. A. Rogel, M. Popliker, C.G. Webb & M. Oren. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5,2851-2855 (1985)

195. S.L. Karp, A. Ortiz, S. Li & E.G. Neilson. Metanephric mesenchymal cells will differentiate in culture after stimulation with hepatocyte growth factor or embryonic spinal cord. Proc Natl Acad Sci USA 91,5286-5290 (1994)

196. C.M. Sorenson, S.A. Rogers, S.J. Korsmeyer & M.R. Hammerman. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol 268,F73-81 (1995)

197. J.A. Kreidberg, H. Sariola, J.M. Loring, M. Maeda, J. Pelletier, D. Housman & R. Jaenisch. WT-1 is required for early kidney development. Cell 74,679-691 (1993)

198. H. Okada, T.M. Danoff, F. Strutz & E.G. Neilson. Generation of a fibroblast-specific conditional lethal gene system: in vitro evaluation. J Am Soc Nephrol 6,905 (1995) abstract

199. W.A. Kennedy, R. Buttyan & I.S. Sawczuk. Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction. J Am Soc Nephrol 4,738 (1993) abstract

200. H.D. Humes, D.A. Cieslinski, T.M. Coimbra, J.M. Messana & C. Galvao. Epidermal growth factor enhances tubule cell regeneration and repair and accelerates the recovery of renal function in postishemic acute renal failure. J Clin Invest 84,1757-1761 (1989)

201. W.A. Border, S. Okuda, L.R. Languino, M.B. Sporn & E. Ruoslahti. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor ß1. Nature 346,371-374 (1990)

202. P. Brooks, A.M.P. Montgomery, M. Rosenfeld, R.A. Reisfeld, T. Hu, G. Klier & D.A. Cheresh. Integrin alpha_vß₃ antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79,1157-1164 (1994)

203. Y. Ren, R.L. Silverstein, J. Allen & J. Savill. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 181,1857-1862 (1995)